Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2018 year
    11
    02 day
    Signing ceremony for Contractubex®50g & Lornithine Laspartate successfully held

    On November 2, 2018, Hongkong Winhealth Pharma Group Co., Ltd and Merz jointly held a grand ceremony in Hangzhou to celebrate the signing of the registration protocol for Contractubex® 50g & Lornithine Laspartate Granules.


    The leaders and senior management of both Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as 'Winhealth Group') and Merz attended the ceremony. The two sides held all-round and heated discussions and exchanges on the marketing of Contractubex®50g and the registration of Lornithine Laspartate Granules. After obtaining the exclusive promotion agency rights of Contractubex®10g and 20g in China in January 2017, Winhealth Group obtained the exclusive distribution right of Contractubex®50g in Mainland China in August 2018. In October 2018, Winhealth Group and Merz signed a registration protocol for Lornithine Laspartate Granules, which further deepened the cooperation with Merz and established a long-term and stable strategic partnership.


    Signing ceremony for Contractubex®50g & Lornithine Laspartate successfully held


    After the celebration ceremony started, the leaders of both sides delivered speeches one after the other. They spoke highly of the cooperation between the two sides, and would work hand in hand to build the brands of Contractubex® and Lornithine Laspartate bigger and stronger in the future. Then the leaders of the two sides left their handprints symbolizing joint progress and development, and drank champagne for celebration.


    After the celebration ceremony was over, the two sides held discussions on the progress of marketing of Contractubex ®50g. Since the contract on Contractubex® 50g was signed in August, work concerning import, business and market has been carried out in an orderly way according to the plan, and the drug is expected to be officially marketed and promoted in March 2019. The Commerce Department of Winhealth Group reported on the preparations for import and drug testing, while the Marketing Department reported on the preparations for the marketing ceremony and the development plan for chain pharmacies. It was decided that a large-scale marketing promotion meeting would be held for Contractubex®50g to start the first shot of the large-scale promotion campaign of the Contractubex brand. 


    As an original drug with an old brand that has been marketed in the world for more than 60 years, Lornithine Laspartate Granules has not been registered in China before due to various reasons. China Food and Drug Administration's policy encouragement on imported drugs this time, especially the original drugs, has brought a positive impact on the domestic registration of Lornithine Laspartate Granules. With its strong capability in market access registration, Winhealth Group has helped Lornithine Laspartate Granules complete registration quickly and enter the Chinese market, bringing benefits to Chinese patients. This discussion mainly focused on the registration data, and listed the problems for both sides to jointly solve.


    Signing ceremony for Contractubex®50g & Lornithine Laspartate successfully held


    Hongkong Winhealth Pharma Group Co., Ltd is committed to introducing high-quality global health products into China, providing patients with more advanced treatment and rehabilitation resources, and contributing to the sustainable development of China's health sector

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.